196
Views
70
CrossRef citations to date
0
Altmetric
Original Research

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging

, , , , , , , , , , , , , & show all
Pages 5223-5238 | Published online: 24 Jul 2017

References

  • LaurentSSaeiAABehzadiSPanahifarAMahmoudiMSuperparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challengesExpert Opin Drug Deliv20141191449147024870351
  • WangYXHussainSMKrestinGPSuperparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imagingEur Radiol200111112319233111702180
  • ChavhanGBBabynPSThomasBShroffMMHaackeEMPrinciples, techniques, and applications of T2*-based MR imaging and its special applicationsRadiographics20092951433144919755604
  • BulteJWKraitchmanDLMonitoring cell therapy using iron oxide MR contrast agentsCurr Pharm Biotechnol20045656758415579045
  • DiwokyCLiebmannDNeumayerBPositive contrast of SPIO-labeled cells by off-resonant reconstruction of 3D radial half-echo bSSFPNMR Biomed2015281798825379657
  • RichardsJMShawCALangNNIn vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humansCirc Cardiovasc Imaging20125450951722787016
  • WalczakPWojtkiewiczJNowakowskiAReal-time MRI for precise and predictable intra-arterial stem cell delivery to the central nervous systemJ Cereb Blood Flow Metab Epub201611 271678X16665853
  • JanowskiMWalczakPPearlMSPredicting and optimizing the territory of blood-brain barrier opening by superselective intra-arterial cerebral infusion under dynamic susceptibility contrast MRI guidanceJ Cereb Blood Flow Metab201636356957526661231
  • EliasATsourkasAImaging circulating cells and lymphoid tissues with iron oxide nanoparticlesHematology Am Soc Hematol Educ Program20091720726
  • TangTYMullerKHGravesMJIron oxide particles for atheroma imagingArterioscler Thromb Vasc Biol20092971001100819229073
  • KooiMECappendijkVCCleutjensKBAccumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imagingCirculation2003107192453245812719280
  • TrivediRAMallawarachiCU-King-ImJMIdentifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophagesArterioscler Thromb Vasc Biol20062671601160616627809
  • HowarthSPTangTYTrivediRUtility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individualsEur J Radiol200970355556018356000
  • DegnanAJPattersonAJTangTYHowarthSPGillardJHEvaluation of ultrasmall superparamagnetic iron oxide-enhanced MRI of carotid atherosclerosis to assess risk of cerebrovascular and cardiovascular events: follow-up of the ATHEROMA trialCerebrovasc Dis201234216917322922841
  • RichardsJMSempleSIMacGillivrayTJAbdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot studyCirc Cardiovasc Imaging20114327428121304070
  • SalehASchroeterMRingelsteinAIron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic strokeStroke200738102733273717717318
  • SadatUHowarthSPUsmanATangTYGravesMJGillardJHSequential imaging of asymptomatic carotid atheroma using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging: a feasibility studyJ Stroke Cerebrovasc Dis2013228e271e27622841932
  • TomitaKTanimotoAIrieREvaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imagingJ Magn Reson Imaging20082861444145019025953
  • AsanumaTOnoMKubotaKSuper paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver diseaseGut201059225826619919948
  • TonanTFujimotoKQayyumACD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlationJ GastroenterolHepatol2012274789796
  • TanimotoAYuasaYShinmotoHSuperparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell functionRadiology2002222366166611867782
  • MalhiHAllenAMWattKDNonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survivalCurr Opin Organ Transplant20162129910626825357
  • BerndHDe KervilerEGaillardSBonnemainBSafety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development programInvest Radiol200944633634219661843
  • YilmazADenglerMAvan der KuipHImaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approachEur Heart J201334646247523103659
  • AlamSRShahASRichardsJUltrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experienceCirc Cardiovasc Imaging20125555956522875883
  • SmitsLPCoolenBFPannoMDNoninvasive differentiation between hepatic steatosis and steatohepatitis with MR imaging enhanced with USPIOs in patients with nonalcoholic fatty liver disease: a proof-of-concept studyRadiology2016278378279126348104
  • MatuszakJDorflerPZalogaJShell matters: Magnetic targeting of SPIONs and in vitro effects on endothelial and monocytic cell functionClin Hemorheol Microcirc201561225927726410877
  • SimbergDParkJHKarmaliPPDifferential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearanceBiomaterials20093023–243926393319394687
  • KurataTTanimotoAShinmotoHYuasaYKuribayashiSQuestionnaire survey of acute and delayed adverse reactions to ferumoxidesRadiat Med200523746847316485536
  • UnterwegerHTietzeRJankoCDevelopment and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug deliveryInt J Nanomedicine201493659367625120363
  • UnterwegerHSubatzusDTietzeRHypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapyInt J Nanomedicine2015106985699626648714
  • CichaIReglerMUrschelKGoppelt-StruebeMDanielWGGarlichsCDResveratrol inhibits monocytic cell chemotaxis to MCP-1 and prevents spontaneous endothelial cell migration through Rho kinase-dependent mechanismJ Atheroscler Thromb201118121031104221878744
  • SzebeniJComplement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicalsMol Immunol201461216317325124145
  • GreishKThiagarajanGHerdHSize and surface charge significantly influence the toxicity of silica and dendritic nanoparticlesNanotoxicology20126771372321793770
  • NabeshiHYoshikawaTMatsuyamaKAmorphous nanosilicas induce consumptive coagulopathy after systemic exposureNanotechnology201223404510122214761
  • MatuszakJBaumgartnerJZalogaJNanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testingNanomedicine (Lond)201611659761627003004
  • BarbieriSSchroederCFroehlichJMPaschAThoenyHCHigh signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcificationContrast Media Mol Imaging201611324525026929131
  • ChaoYKarmaliPPSimbergDRole of carbohydrate receptors in the macrophage uptake of dextran-coated iron oxide nanoparticlesAdv Exp Med Biol201273311512322101717
  • IancuTCUltrastructural pathology of iron overloadBaillieres Clin Haematol1989224754952660938
  • CapernaTJFaillaMLSteeleNCRichardsMPAccumulation and metabolism of iron-dextran by hepatocytes, Kupffer cells and endothelial cells in the neonatal pig liverJ Nutr198711723123203559746
  • SzebeniJBedőcsPCsukásDRosivallLBungerRUrbanicsRA porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicinesAdv Drug Deliv Rev201264151706171622820530